Last reviewed · How we verify
NCT06857526
The Relationship of Hand Sensory and Strength Assessments with Functionality and Kinesiophobia in Individuals with Rheumatoid Arthritis
trial in Disease in 50 participants. Not yet recruiting.
25 May 2025
Quick facts
| Lead sponsor | Firat University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 5 March 2025 |
| Primary completion | 25 May 2025 |
| Estimated completion | 5 June 2025 |
Conditions studied
- Disease — all drugs for Disease →
Sponsor
Firat University
Who can join
Adults 18 to 65, any sex, with Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Rheumatoid arthritis (RA) is a systemic inflammatory disease that can involve all tissues with synovium. The wrist and hand, which are of great importance in our daily activities, are involved early and specifically because they are rich in synovium, which is the target tissue in RA.In many patients with rheumatoid arthritis, hand and wrist involvement is seen from the early stages of the disease. Pain, stiffness and swelling in the joint are accompanied by decreased range of motion and muscle strength.Hand functions have a very important place due to the fact that the hand must be used in countless daily life activities.Kinesiophobia is defined as a state of fear and avoidance of activity and physical movement caused by painful injury and sensitivity to repeated injury.The aim of this study was to investigate the relationship between hand sensory and strength assessment, functionality and kinesiophobia in individuals with rheumatoid arthritis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06857526
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Disease
Currently open trials in the same condition.
- NCT06271538 — Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome · Phase 4 · recruiting
- NCT06081452 — Public Survey on Breath Testing for Health and Disease · recruiting
- NCT06812091 — Human Microbiome Research and Development for Overcoming Pediatric Diseases · recruiting
Other Firat University trials
Trials by the same sponsor.
- NCT07520799 — The Effect of Mindfulness-Based Breathing Exercises on Dyspnea, Symptom Control, and Quality of Life in Lung Cancer Pati · NA · not yet recruiting
- NCT07520773 — Therapeutic Touch on Sleep, Comfort, and Physiological Parameters in Intensive Care Patients · NA · not yet recruiting
- NCT07521995 — Impact of Exercise Training on Serum Glial Fibrillary Acidic Protein (GFAP), Brain Volumetry, and Functional Outcomes in · NA · not yet recruiting
- NCT07520812 — Impact of Exercise Training on Serum Neurofilament Light Chain (NfL), Brain Volumetry, and Functional Outcomes in Multip · NA · not yet recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06857526 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Firat University
- Last refreshed: 4 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06857526.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing